Abstract
1131 Background: Triple-negative breast cancer corresponds to 15-20% of cases. Despite the advances in development of therapies for breast cancer treatment, this subtype still have a dismal prognos...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
